Biohaven (BHVN) Net Income (2021 - 2026)
Biohaven (BHVN) reported Net Income of -$130.5 million for Q1 2026, up 41.12% on a YoY basis from -$92.5 million in Q1 2025, and up 10.32% sequentially from -$145.6 million in Q4 2025.
Biohaven (BHVN) Net Income (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Net Income data on file, last reported at -$130.5 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income rose 41.12% year-over-year to -$130.5 million; the trailing twelve-month figure through Mar 2026 stood at -$647.7 million (up 27.11% YoY), and the FY2025 full-year result was -$738.8 million, up 12.71% from the prior year.
- Net Income advanced to -$130.5 million in Q1 2026, from -$145.6 million in the prior quarter.
- In the past five years, Net Income ranged from a high of -$68.9 million in Q3 2022 to a low of -$319.8 million in Q2 2024.
- A 5-year average of -$158.5 million and a median of -$160.3 million in 2024 frame the typical range for Net Income.
- Across the five-year window, Net Income plunged 287.59% in 2022 and soared 55.56% in 2023, its largest moves.
- Tracing BHVN's Net Income over 5 years: stood at -$201.1 million in 2022, then gained by 28.02% to -$144.8 million in 2023, then fell by 29.07% to -$186.8 million in 2024, then advanced by 22.1% to -$145.6 million in 2025, then advanced by 10.32% to -$130.5 million in 2026.
- Business Quant data shows BHVN's Net Income at -$130.5 million in Q1 2026, -$145.6 million in Q4 2025, and -$173.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | -130.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.53 Mn |
| Dec 31, 2025 | -145.56 Mn |
| Sep 30, 2025 | -173.44 Mn |
| Jun 30, 2025 | -198.15 Mn |
| Mar 31, 2025 | -221.68 Mn |
| Dec 31, 2024 | -186.84 Mn |
| Sep 30, 2024 | -160.30 Mn |
| Jun 30, 2024 | -319.77 Mn |
| Mar 31, 2024 | -179.50 Mn |
| Dec 31, 2023 | -144.76 Mn |
| Sep 30, 2023 | -102.57 Mn |
| Jun 30, 2023 | -90.35 Mn |
| Mar 31, 2023 | -70.49 Mn |
| Dec 31, 2022 | -201.11 Mn |
| Sep 30, 2022 | -68.85 Mn |
| Jun 30, 2022 | -203.29 Mn |
| Mar 31, 2022 | -97.03 Mn |
| Dec 31, 2021 | -51.89 Mn |
| Sep 30, 2021 | -54.37 Mn |